NASDAQ:AMRN

Thinking about buying stock in Oncolytics Biotech, Amarin Corporation, Biophytis, bluebird bio, or VERSES AI?

Retrieved on: 
Wednesday, July 19, 2023
Main Street, Wall Street, Multimedia, Security (finance)

Each stock is evaluated based on short-term technical, long-term technical and fundamental factors.

Key Points: 
  • Each stock is evaluated based on short-term technical, long-term technical and fundamental factors.
  • Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.
  • InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street.
  • We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

Sarissa Capital Wins Proxy Contest Against Amarin by Huge Landslide

Retrieved on: 
Tuesday, February 28, 2023
Professional Services, Health, Finance, Banking, Pharmaceutical, Biotechnology, ALL, Annual general meeting, WORK, Amarin, Mass meeting, Patient, Professional corporation, Wall Street, Pershing Square Capital Management, Holding company, Security (finance), Sarissa

Sarissa Capital Management LP today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN):

Key Points: 
  • Sarissa Capital Management LP today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN):
    Amarin shareholders have sent a loud and clear message repudiating the incumbent Amarin board.
  • Sarissa thanks fellow shareholders for their support in a resounding victory against the Amarin board.
  • Sarissa Capital Management LP (“Sarissa Capital”), together with other participants, filed a definitive proxy statement and an accompanying blue proxy card with the SEC on January 31, 2023, in connection with the solicitation of shareholders of Amarin Corporation plc (the “Company”) at the general meeting of the Company for the election of Sarissa Capital’s slate of highly-qualified nominees (the “General Meeting”).
  • The definitive proxy statement and other relevant documents are also available at no charge by directing a request to Sarissa Capital’s proxy solicitor, D.F.

Sarissa Capital Condemns Amarin Board for Frontrunning Results of Proxy Contest With Egregious Equity Grants to Executives

Retrieved on: 
Monday, February 27, 2023
Banking, Professional Services, Finance, Sarissa, Annual general meeting, Betrayal, Amarin, Mass meeting, Professional corporation, Wall Street, Mouth, Geode Capital Management, Wind, Disclosure, Management, Auction, Security (finance)

Sarissa has been urging the Amarin board to release the results of the proxy contest for several days.

Key Points: 
  • Sarissa has been urging the Amarin board to release the results of the proxy contest for several days.
  • Late last week in the stealth of night and right before the General Meeting, the Amarin board disclosed egregious equity grants to executives representing more than 3.6 million shares.
  • Prior equity grants to these employees have been significantly impaired by the incompetence of the Amarin board.
  • Sarissa will work tirelessly to hold bad actors on the Amarin board accountable and to overhaul the board for the benefit of shareholders.

Sarissa Capital Reminds Amarin Shareholders Today Is the Last Day to Vote “FOR” Change

Retrieved on: 
Tuesday, February 21, 2023
Biotechnology, Finance, Health, Professional Services, Cardiology, MAKE, Sarissa, Annual general meeting, BUT, Mass meeting, Professional corporation, Wall Street, Sequah Medicine Company, Lip, Glenview Capital Management, Sale, NOT, Holding company, Management, Security (finance), Auction, Amarin

Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN):

Key Points: 
  • Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN):
    Sarissa urges Amarin shareholders to vote “FOR” change TODAY to remake the Amarin board for shareholders at our upcoming meeting.
  • Shareholders have seen tremendous value destruction at the hands of current Amarin leadership with its operational blunders and poor capital allocation decisions.
  • Visit our website at www.freeamarin.com for helpful information about Sarissa and the need for change at Amarin.
  • The General Meeting of Amarin shareholders is scheduled for February 28, 2023, BUT TO MAKE SURE YOUR VOTE COUNTS, SUBMIT YOUR VOTE BY MIDNIGHT (NEW YORK TIME) TONIGHT.

Sarissa Capital Urges Amarin Shareholders to Vote “FOR” Necessary Change

Retrieved on: 
Monday, February 20, 2023
Biotechnology, Finance, Health, Professional Services, Cardiology, MAKE, Patient, Sale, BUT, Sequah Medicine Company, History, NOT, Wall Street, Mass meeting, Professional corporation, Annual general meeting, Pershing Square Capital Management, Bank, Management, Internet service provider, Auction, Security (finance), Sarissa, Amarin

Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN):

Key Points: 
  • Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN):
    Sarissa urges Amarin shareholders to vote “FOR” necessary change at our upcoming shareholder meeting.
  • Amarin is at a critical juncture where strategic decisions must be made by a board that seeks to leverage the strengths of the company’s assets for the benefit of shareholders.
  • Visit our website at www.freeamarin.com for helpful information about Sarissa and the need for change at Amarin.
  • The General Meeting of Amarin shareholders is scheduled for February 28, 2023, BUT TO MAKE SURE YOUR VOTE COUNTS, SUBMIT YOUR VOTE ON OR BEFORE TUESDAY, FEBRUARY 21, 2023.

Sarissa Capital Urges Amarin Shareholders to Vote for Change and Remake Amarin for Shareholders

Retrieved on: 
Friday, February 17, 2023
Finance, Health, Professional Services, Pharmaceutical, Cardiology, MAKE, Sarissa, Patient, Sale, BUT, Sequah Medicine Company, Amarin Corporation, NOT, Wall Street, Mass meeting, Professional corporation, Annual general meeting, Glenview Capital Management, Internet service provider, Auction, Ethyl eicosapentaenoic acid, Amarin

Sarissa Capital Management LP (“Sarissa”) today issued a presentation detailing the dire need for change at Amarin Corporation plc (NASDAQ: AMRN) accessible at the link below:

Key Points: 
  • Sarissa Capital Management LP (“Sarissa”) today issued a presentation detailing the dire need for change at Amarin Corporation plc (NASDAQ: AMRN) accessible at the link below:
    Amarin shareholders face an important decision at our upcoming shareholder meeting.
  • The value of Vascepa, however, continues to be wasted by the company due to its mismanagement and poor capital allocation decisions.
  • Visit our website at www.freeamarin.com for helpful information about Sarissa and the need for change at Amarin.
  • The General Meeting of Amarin shareholders is scheduled for February 28, 2023, BUT TO MAKE SURE YOUR VOTE COUNTS, SUBMIT YOUR VOTE ON OR BEFORE TUESDAY, FEBRUARY 21, 2023.

Sarissa Capital Blasts Amarin’s Repeated False Statements; Clearly Amarin Will Say Anything to Keep Sarissa Off the Board

Retrieved on: 
Thursday, February 16, 2023
Professional Services, Health, Finance, Pharmaceutical, Cardiology, Biotechnology, MAKE, Capital, BUT, NOT, Wall Street, Mass meeting, Professional corporation, Annual general meeting, Glenview Capital Management, Security (finance), Auction, Internet service provider, Sarissa, Amarin

Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN):

Key Points: 
  • Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN):
    Sarissa Capital is outraged but not surprised by Amarin’s repeated false statements intended to mislead shareholders and switch votes away from Sarissa.
  • Clearly, Amarin is willing to say anything to keep Sarissa, its largest shareholder, off the board.
  • Sarissa is confident that fellow long-suffering shareholders see through the ploys and will vote “FOR” necessary change.
  • Sarissa urges all shareholders to ignore the false statements and empty promises made by Amarin and make up their own minds.

Sarissa Capital Uncovers That Amarin’s Registrar Had Not Been Instructed to Accept Blue Proxy Cards Even Though Legally Required to Do So

Retrieved on: 
Wednesday, February 15, 2023
Professional Services, Health, Finance, Pharmaceutical, Cardiology, Biotechnology, MAKE, Sarissa, BUT, NOT, Wall Street, Mass meeting, Professional corporation, Annual general meeting, Pershing Square Capital Management, Auction, Security (finance), Internet service provider, Amarin

Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN):

Key Points: 
  • Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN):
    Sarissa Capital, in voting its shares, uncovered that Amarin’s registrar, the firm retained by Amarin to receive and process proxy cards, had not been instructed to accept blue proxy cards even though legally required to do so.
  • Amarin’s registrar believed it was only authorized to accept and process the white proxy cards.
  • Fortunately for shareholders, Sarissa acted to correct this problem and all votes that have been or will be submitted on the blue proxy card will be accepted.
  • IF YOU ALREADY VOTED “FOR” ALL PROPOSALS AND SUBMITTED YOUR BLUE PROXY CARD, THERE IS NOTHING ELSE YOU NEED TO DO TO SUPPORT SARISSA’S NOMINEES.

Sarissa Capital Disappointed That Amarin Webcast Continues Board’s Defense of Poor Results and Lack of Accountability

Retrieved on: 
Tuesday, February 14, 2023
Finance, Health, Professional Services, Pharmaceutical, Cardiology, MAKE, Sarissa, Novartis, Frustration, Face, Capital, BUT, NOT, Wall Street, BLUE, Mass meeting, Professional corporation, Annual general meeting, Glenview Capital Management, Management, Security (finance), Cryptocurrency, Internet service provider, Auction, Amarin

Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN):

Key Points: 
  • Sarissa Capital Management LP (“Sarissa”) today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN):
    Sarissa Capital believes that today’s Amarin webcast was yet again tone-deaf to shareholders and another display by management of a lack of accountability for its poor performance.
  • This is the first time in his two-year tenure that the company hosted a webcast aimed at its retail shareholder base.
  • Board Member Erin Enright also indicated Amarin’s high compensation levels in the face of the company’s poor results are warranted.
  • Amarin was unable to secure German reimbursement and continues to blame external factors without taking any accountability.

Sarissa Capital Warns of Amarin’s Expensive Attempts to Switch Votes by Inundating Shareholders With White Proxy Cards

Retrieved on: 
Monday, February 13, 2023
Professional Services, Health, Other Professional Services, Finance, Pharmaceutical, Cardiology, Biotechnology, MAKE, BUT, Wall Street, BLUE, Removal, Professional corporation, Mass meeting, Annual general meeting, Pershing Square Capital Management, History, Cryptocurrency, Internet service provider, Auction, Security (finance), Sarissa, Amarin

The most recent waste of money comes in the form of several expensive and duplicative mailings of white proxy cards to shareholders in an attempt to sway votes away from Sarissa.

Key Points: 
  • The most recent waste of money comes in the form of several expensive and duplicative mailings of white proxy cards to shareholders in an attempt to sway votes away from Sarissa.
  • We urge all shareholders to vote the BLUE proxy card “FOR” the Sarissa Nominees and “FOR” the removal of Chairman Per Wold-Olsen.
  • Voting “FOR” on the white proxy card has the same effect as voting “FOR” on the BLUE proxy card.
  • The definitive proxy statement and other relevant documents are also available at no charge by directing a request to Sarissa Capital’s proxy solicitor, D.F.